Secretory products from human adipocytes impair endothelial function via nuclear factor κB

Atherosclerosis

Volumn 196, Issue 2, 2008, Pages 523-531

  Kralisch, Susan ^a   Sommer, Grit ^a   Stangl, Verena ^b   Köhler, Uwe ^c   Kratzsch, Jürgen ^a   Stepan, Holger ^a   Faber, Renaldo ^a   Schubert, Andreas ^d   Lössner, Ulrike ^a   Vietzke, Angelika ^b   Bluher, Matthias ^a,e   Stumvoll, Michael ^a,e   Fasshauer, Mathias ^a,e  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Klinikum St Georg   (Germany)

^d FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

^e UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Adipocyte; Adipokine; Endothelial dysfunction; Fat; Obesity

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1;

ADIPOCYTE; ARTICLE; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL SECRETION; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UMBILICAL VEIN;

ADIPOCYTES; ADIPOKINES; APOPTOSIS; CELL ADHESION; CELLS, CULTURED; E-SELECTIN; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LEPTIN; LEUPEPTINS; NF-KAPPA B; RESISTIN; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 38349108765     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.05.016     Document Type: Article

References (49)

1. Fasshauer M., and Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 46 (2003) 1594-1603
2. Brook R.D., Bard R.L., Rubenfire M., Ridker P.M., and Rajagopalan S. Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults. Am J Cardiol 88 (2001) 1264-1269
3. Williams I.L., Chowienczyk P.J., Wheatcroft S.B., et al. Effect of fat distribution on endothelial-dependent and endothelial-independent vasodilatation in healthy humans. Diabetes Obes Metab 8 (2006) 296-301
4. Suh H.S., Park Y.W., Kang J.H., et al. Vascular endothelial dysfunction tested by blunted response to endothelium-dependent vasodilation by salbutamol and its related factors in uncomplicated pre-menopausal obese women. Int J Obes (Lond) 29 (2005) 217-222
5. Watts K., Beye P., Siafarikas A., et al. Exercise training normalizes vascular dysfunction and improves central adiposity in obese adolescents. J Am Coll Cardiol 43 (2004) 1823-1827
6. Vazquez L.A., Pazos F., Berrazueta J.R., et al. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab 90 (2005) 316-322
7. McKay M.K., and Hester R.L. Role of nitric oxide, adenosine, and ATP-sensitive potassium channels in insulin-induced vasodilation. Hypertension 28 (1996) 202-208
8. Fasshauer M., Paschke R., and Stumvoll M. Adiponectin, obesity, and cardiovascular disease. Biochimie 86 (2004) 779-784
9. Shimabukuro M., Higa N., Asahi T., et al. Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 88 (2003) 3236-3240
10. Ouchi N., Kihara S., Arita Y., et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103 (2001) 1057-1063
11. Hotamisligil G.S. The role of TNFalpha and TNF receptors in obesity and insulin resistance. J Intern Med 245 (1999) 621-625
12. Aldhahi W., and Hamdy O. Adipokines, inflammation, and the endothelium in diabetes. Curr Diab Rep 3 (2003) 293-298
13. Wang P., Ba Z.F., and Chaudry I.H. Administration of tumor necrosis factor-alpha in vivo depresses endothelium-dependent relaxation. Am J Physiol 266 (1994) H2535-H2541
14. Bhagat K., and Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 96 (1997) 3042-3047
15. Schafer K., Halle M., Goeschen C., et al. Leptin promotes vascular remodeling and neointimal growth in mice. Arterioscler Thromb Vasc Biol 24 (2004) 112-117
16. Singhal A., Farooqi I.S., Cole T.J., et al. Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease?. Circulation 106 (2002) 1919-1924
17. Kawanami D., Maemura K., Takeda N., et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun 314 (2004) 415-419
18. Verma S., Li S.H., Wang C.H., et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108 (2003) 736-740
19. Savage D.B., Sewter C.P., Klenk E.S., et al. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 50 (2001) 2199-2202
20. Jaffe E.A., Nachman R.L., Becker C.G., and Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52 (1973) 2745-2756
21. Kratzsch J., Berthold A., Lammert A., et al. A rapid, quantitative immunofunctional assay for measuring human leptin. Horm Res 57 (2002) 127-132
22. Grau G.E., and Lou J. TNF in vascular pathology: the importance of platelet-endothelium interactions. Res Immunol 144 (1993) 355-363
23. Myers P.R., Parker J.L., Tanner M.A., and Adams H.R. Effects of cytokines tumor necrosis factor alpha and interleukin 1 beta on endotoxin-mediated inhibition of endothelium-derived relaxing factor bioactivity and nitric oxide production in vascular endothelium. Shock 1 (1994) 73-78
24. Hermann C., Assmus B., Urbich C., Zeiher A.M., and Dimmeler S. Insulin-mediated stimulation of protein kinase Akt: a potent survival signaling cascade for endothelial cells. Arterioscler Thromb Vasc Biol 20 (2000) 402-409
25. Burnett M.S., Lee C.W., Kinnaird T.D., et al. The potential role of resistin in atherogenesis. Atherosclerosis 182 (2005) 241-248
26. Quehenberger P., Exner M., Sunder-Plassmann R., et al. Leptin induces endothelin-1 in endothelial cells in vitro. Circ Res 90 (2002) 711-718
27. Bouloumie A., Marumo T., Lafontan M., and Busse R. Leptin induces oxidative stress in human endothelial cells. FASEB J 13 (1999) 1231-1238
28. Park H.Y., Kwon H.M., Lim H.J., et al. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med 33 (2001) 95-102
29. Skilton M.R., Nakhla S., Sieveking D.P., Caterson I.D., and Celermajer D.S. Pathophysiological levels of the obesity related peptides resistin and ghrelin increase adhesion molecule expression on human vascular endothelial cells. Clin Exp Pharmacol Physiol 32 (2005) 839-844
30. Ouchi N., Kihara S., Arita Y., et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100 (1999) 2473-2476
31. Ouchi N., Kihara S., Arita Y., et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102 (2000) 1296-1301
32. Chen H., Montagnani M., Funahashi T., Shimomura I., and Quon M.J. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 278 (2003) 45021-45026
33. Kobayashi H., Ouchi N., Kihara S., et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 94 (2004) e27-e31
34. Wilson S.H., Best P.J., Edwards W.D., et al. Nuclear factor-kappaB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris. Atherosclerosis 160 (2002) 147-153
35. Siebenlist U., Franzoso G., and Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 10 (1994) 405-455
36. Chia M.C. The role of adhesion molecules in atherosclerosis. Crit Rev Clin Lab Sci 35 (1998) 573-602
37. Wang T.D., Chen W.J., Lin J.W., Chen M.F., and Lee Y.T. Effects of rosiglitazone on endothelial function, C-reactive protein, and components of the metabolic syndrome in nondiabetic patients with the metabolic syndrome. Am J Cardiol 93 (2004) 362-365
38. Campia U., Matuskey L.A., and Panza J.A. Peroxisome proliferator-activated receptor-gamma activation with pioglitazone improves endothelium-dependent dilation in nondiabetic patients with major cardiovascular risk factors. Circulation 113 (2006) 867-875
39. Dormandy J.A., Charbonnel B., Eckland D.J., et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (prospective pioglitazone clinical trial in macrovascular events): a randomised controlled trial. Lancet 366 (2005) 1279-1289
40. Lehrke M., and Lazar M.A. The many faces of PPARgamma. Cell 123 (2005) 993-999
41. Yu J.G., Javorschi S., Hevener A.L., et al. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 51 (2002) 2968-2974
42. Motoshima H., Wu X., Sinha M.K., et al. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab 87 (2002) 5662-5667
43. Yang W.S., Jeng C.Y., Wu T.J., et al. Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care 25 (2002) 376-380
44. Combs T.P., Wagner J.A., Berger J., et al. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology 143 (2002) 998-1007
45. Hallakou S., Doare L., Foufelle F., et al. Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat. Diabetes 46 (1997) 1393-1399
46. Zhang B., Graziano M.P., Doebber T.W., et al. Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice. J Biol Chem 271 (1996) 9455-9459
47. Kallen C.B., and Lazar M.A. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 93 (1996) 5793-5796
48. de Vos P., Lefebvre A.M., Miller S.G., et al. Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma. J Clin Invest 98 (1996) 1004-1009
49. Okuno A., Tamemoto H., Tobe K., et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 101 (1998) 1354-1361